Navigation Links
Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008
Date:2/25/2009

ging study in heterozygous FH subjects and long-term dosing data in FH patients exposed to mipomersen from three to 23 months.
  • Publishing preclinical data showing that lowering of apoB-100 resulted in significant reduction of atherosclerotic plaques in murine models of atherosclerosis.
  • In addition, Isis and its partners showed encouraging clinical results in a broad range of diseases including,

    • Encouraging Phase 2 data of OGX-011 in prostate cancer patients showing survival advantage, durable reductions in pain, and declines in PSA.
    • Positive Phase 2 results showing that ATL/TV1102 demonstrated a highly significant effect on disease activity in patients with multiple sclerosis.
    • Interim data from an ongoing Phase 1 study showing that iCo-007 appears to be well tolerated in patients with diffuse diabetic macular edema.

    Isis broadened its pipeline with the addition of new drugs that Isis' partners are developing including,

    • An antisense drug that targets PCSK9, BMS-PCSK9Rx.
    • An antisense drug for the local treatment of fibrosis and scarring, EXC001.
    • A novel aminoglycoside drug, ACHN-490, which Achaogen is developing to treat bacterial infections.

    Isis' pipeline matured with the initiation of clinical trials in multiple drugs including,

    • ISIS-CRPRx to treat coronary artery disease, inflammation and end-stage renal disease.
    • ISIS-SGLT2Rx to treat type 2 diabetes.
    • AIR645 to treat asthma.
    • LY2181308 to treat cancer.

    Corporate Highlights

    Isis continued to execute its successful business strategy by monetizing key assets with partners to continue the development and commercialization of the assets with
    '/>"/>

    SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine news :

    1. Lehigh Valley-Based PPO, Valley Preferred, Reports Marked Improvement in Disease Management & Wellness Outcomes
    2. Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
    3. Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results
    4. ev3 Inc. Reports 2008 Fourth Quarter and Full-Year Financial Results and 2009 Guidance
    5. Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
    6. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2008
    7. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
    8. Solta Medical Reports Fourth Quarter and Full Year 2008 Results
    9. 1 in 10 Ex-NFL Players Used Steroids, Poll Reports
    10. ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
    11. Nyer Medical Group, Inc. Reports Revenues of $19.0 Million for the Quarter Ended December 31, 2008
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2015)... ... August 29, 2015 , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the ... (Meso Foundation) will present an educational program titled “Asbestos and Your Health.” , The ... PM (doors open at 6:45pm) at Calvary United Methodist Church, 16 E Park Ave., ...
    (Date:8/29/2015)... ... ... like Toppik , Eau Thermale Avene and Bliss are now available on ... required to qualify for free standard shipping,” said Jennifer Ramirez, the public relations manager. ... the item’s selling price.” , With competitive pricing in the e-commerce market for beauty ...
    (Date:8/29/2015)... ... ... popular television program VOICES IN AMERICA, hosted by legendary star of the stage and ... segment to the subject of diabetes. Diabetes is a debilitating health condition that is ... advancements in medical science may prove to be a significant breakthrough that sufferers have ...
    (Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 United Methodists are ... children helping children, a thank you to the many creative and generous ways ... the United Methodist initiative to end malaria deaths. , The Columbus Zoo and ...
    (Date:8/28/2015)... VA (PRWEB) , ... August ... ... Risk Management for Medical Devices:, Understanding the FDA’s Position and Best Practices ... MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally renowned expert ...
    Breaking Medicine News(10 mins):Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5
    ... A free white paper is now,available to help ... requirements and unannounced surveys at:, http://www.eheinc.com/jcaho.htm . ... 2006,Unannounced Survey Policy within the Environment of Care, ... engineering and consulting firm,the white paper reviews the ...
    ... AMERIGROUP,Corporation (NYSE: AGP ) today announced that ... Conference on November 27 in New,York City. A ... 27 at 2:00 p.m. Eastern Time, can be accessed ... page. A replay will be,available for 30 days, and ...
    ... Tool is believed to be first in nation offered by a health ... ... 13 Group Health Incorporated (GHI) has,announced that GHI will provide what ... the nation offered by a health,insurance plan. Effective November 9, 2007, all ...
    ... Together Cancer Funding Organizations, Advocates, Government Agencies, and Scientists ... ... NEW YORK, Nov. 13 Leadership and senior staff ... met,on November 1-2 along with experts from government agencies, ...
    ... the University of Southern California,s Mara Mather as the ... This distinguished honor recognizes insightful and innovative publications on ... social sciences. , The award presentation will take place ... held from November 16th - 20th, 2007 in San ...
    ... have a Made In Israel stamp on it? American donors ... a very good chance it could. , In September 2007, ... Universitys Prof. Yossi Shiloh from the Department of Human Molecular ... tens of thousands more to eight other researchers at the ...
    Cached Medicine News:Health News:Free White Paper Details Hospital Strategies for Meeting Joint Commission Compliance Requirements in the Environment of Care 2Health News:GHI Introduces Online Pediatric Health Risk Assessment 2Health News:First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 2Health News:First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 3Health News:First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 4Health News:American donors put faith (and dollars) in TAU cancer research 2Health News:American donors put faith (and dollars) in TAU cancer research 3
    (Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... has announced the addition of the "Investigation ... report to their offering. Developed by ... of Novolog) is an important drug for the ... aspart, as a fast- acting insulin analog, starts ...
    (Date:8/28/2015)... 28, 2015 Perrigo Company plc ("Perrigo") (NYSE: ... N.V. ("Mylan") (NASDAQ: MYL ) shareholder vote regarding ... "Our views of Mylan,s offer to Perrigo shareholders have ... our Board,s careful reflection of the value available to ... choices that Mylan has allowed its shareholders to consider," ...
    (Date:8/28/2015)... India , August 28, 2015 ... Oils), Livestock (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by Region ... , Asia-Pacific , and Rest of the ... MarketsandMarkets, The global market for Eubiotics was valued at USD ... 7.05 Billion by 2020, at a CAGR of 7.4% from ...
    Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5
    ... Columbia Laboratories, Inc. (Nasdaq: CBRX ), ... today confirmed that the Advisory Committee for Reproductive Health ... is scheduled to review Columbia,s New Drug Application (NDA) ... of preterm birth in women with short uterine cervical ...
    ... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... been named to the role of Executive Vice President ... employment with Valeant, which is expected to be December ... Sachs where he was the chief operating officer for ...
    Cached Medicine Technology:Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 2Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 3Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 4Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer 2Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer 3
    Inquire...
    Inquire...
    ... Implants come in three styles. Each style ... far the most popular style. Pectoral Implants ... packaged and sold individually, not in pairs. ... are each made for a specific side ...
    ... in the IQmark family elevates your ECG and ... portability, cost-savings and efficient patient care. The IQmark ... the office, clinics and medical centers as well ... used in conjunction with the IQmark Digital ECG ...
    Medicine Products: